A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL

Brief description of study

Detailed Study Description

The feasibility will be evaluated in terms of complete remission rate, duration of complete remission, disease-free survival, overall survival, and toxicities.

Clinical Study Identifier: NCT00774332

Start Over

Asan Medical Center

Seoul, Korea, Republic of

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up now »

Powered by